Otherwise well recently, no sick contacts, no exotic travel history.
Associated symptoms; no chest pain, syncope or palpitations, maybe some left thigh pain but only on prompting
A distant history of what sounds like an unprovoked DVT with unclear follow up but hasn't been on "the rat poison" for years.
Looks dreadful! Cyanotic but talking in short phrases RR 70 Sats 84% RA (89-91% 15L NRBM) BP 96/48 HR 120 Afebrile | Good AE (when she can) HSD NM JVP approx 6cm Calves SNT without pedal oedema |
Such sudden drastic deterioration is likely due to a heart (AMI), lung (PXT) or vascular problem (PE, Dissection in coronaries).
And sepsis...sepsis is always on the radar
Bedside
ECG - Sinus Tachy, maybe some R heart strain but definitly nothing to catheterise at this stage
VBG - machine broken, being sent to the lab
BSL - 9
Cxr - radiographer on the way
The patients sick and the decision is made for CT to rule out the immediate life threats in the not-so-good looking patient.
CT
So what are we going to order? Non-Con vs CTPA vs Aortagram vs CTCA? The hooves sound like horses so lets go with the CTPA...
Occlusive thrombus in R main pulmonary artery (shown image 1)
Thrombi in L lobar pulmonary arterial branches
Evidence of R heart strain
Flattening of the interventricular septum
Reflux of contrast into the hepatic arteries and IVC (shown image 2)
American Heart Association Grading
MASSIVE SBP< 90mmHg (15mins or ionotropes) OR Profound bradycardia with signs of shock OR Pulselessness (this is bad) | SUBMASSIVE SBP>90mmHg with evidence of RV dysfunction (on CTPA, Echo or "Biomarkers") | NON-MASSIVE Everything else! |
SBP > 100mmHg + CTPA shows RV dysfunction + Oh, and the bloods are back...hsTn 119 = SUBMASSIVE
Nothing or Anticoagulant or Lyse (systemic or interventional radiology) or Embolectomy or Nothing
Some Evidence Around Lysis... | (click on pictures for articles where available) |
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism (PEITHO Trial) 2014
NNT 33 vs NNH 13.7 Trend toward decreased mortality (non-sig) but increased bleeding (non-sig). Does not support thrombolysis in submassive PE | Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial) 2013
ARR 41%, NNT 2.4 Difficult to interpret study as measured echocardiographic outcomes | Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism. 2014
|
- There is a role for thrombolysis in submassive PE.
- The ‘Submassive’ group is too disparate to find an effect based on current definitions.
Named after the practitioner who provided most of the above information, it is a stream of consciousness that consolidates the evidence and the stuff between the lines
- Some "submassives" are on the way to being massive
- Thrombolysis zeal post N=1 has deflated
- Still a little confused but less than before
PESI (Pulmonary Embolism Severity Index) scores 30 day mortality (does not include all the following)
Suggested Interpretation of Score Very Low (≤ 65) or Low Risk (66-85) by the PESI score.
|